Grant: Alliance Grants
University of British Columbia
$25,000.00
Mechanisms for antibiotic tolerance and envelope remodeling in Gram-negative bacteria
FY 2022-23
Summary
This collaboration between Elitza Tocheva at the University of British Columbia and Tobias Dörr at Cornell University seeks to elucidate mechanisms of bacterial envelope morphogenesis and antibiotic tolerance while providing quality training to their research teams. The diverse Gram-negative bacteria at the center of this research display a robust ability to survive catastrophic envelope damage and the loss of their cell walls. These bacteria can compensate for cell wall deficiency until the damaging agent, i.e., a cell wall-acting antibiotic like penicillin, is removed and they can regenerate their cell walls. This phenomenon is termed "antibiotic tolerance." As the bacterial cell wall is the target of several classes of antibiotics, it is critical that we understand the mechanisms that permit these tolerant bacteria to survive cell wall-targeting antibiotics. Observing the recovery of these tolerant bacteria from a cell wall-deficient state back to a walled state also presents an opportunity to tackle the elusive yet fundamental question of how rod-shaped bacteria establish their cell shape without the template of a pre-existing cell wall. The Tocheva and Dörr groups will apply a unique and powerful combination of advanced, high-resolution cryo-electron tomography, genetics, and biochemistry to these understudied and historically difficult research questions. Genetic screens performed by the Dörr lab in V. cholerae, E. cloacae, and K. pneumoniae have identified key bacterial stress response systems and envelope biogenesis pathways that contribute to antibiotic tolerance. These studies are the source of numerous hypotheses regarding the roles of each layer in the Gram-negative bacterial envelope during cell wall degradation and regeneration that will be probed by the Tocheva lab via cryo-electron tomography and correlative fluorescent microscopy techniques. This trainee-driven project will establish Canadian expertise in both fundamental bacteriology and the emerging field of antibiotic tolerance.
Program
Alliance Grants
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
571867-2021
Name nom
Tocheva, Elitza E
Department département
Microbiology and Immunology
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2021
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Installment
inst:1
Partie
1
Nb partie
1
Application title
Mechanisms for antibiotic tolerance and envelope remodeling in Gram-negative bacteria
Application summary
This collaboration between Elitza Tocheva at the University of British Columbia and Tobias Dörr at Cornell University seeks to elucidate mechanisms of bacterial envelope morphogenesis and antibiotic tolerance while providing quality training to their research teams. The diverse Gram-negative bacteria at the center of this research display a robust ability to survive catastrophic envelope damage and the loss of their cell walls. These bacteria can compensate for cell wall deficiency until the damaging agent, i.e., a cell wall-acting antibiotic like penicillin, is removed and they can regenerate their cell walls. This phenomenon is termed "antibiotic tolerance." As the bacterial cell wall is the target of several classes of antibiotics, it is critical that we understand the mechanisms that permit these tolerant bacteria to survive cell wall-targeting antibiotics. Observing the recovery of these tolerant bacteria from a cell wall-deficient state back to a walled state also presents an opportunity to tackle the elusive yet fundamental question of how rod-shaped bacteria establish their cell shape without the template of a pre-existing cell wall. The Tocheva and Dörr groups will apply a unique and powerful combination of advanced, high-resolution cryo-electron tomography, genetics, and biochemistry to these understudied and historically difficult research questions. Genetic screens performed by the Dörr lab in V. cholerae, E. cloacae, and K. pneumoniae have identified key bacterial stress response systems and envelope biogenesis pathways that contribute to antibiotic tolerance. These studies are the source of numerous hypotheses regarding the roles of each layer in the Gram-negative bacterial envelope during cell wall degradation and regeneration that will be probed by the Tocheva lab via cryo-electron tomography and correlative fluorescent microscopy techniques. This trainee-driven project will establish Canadian expertise in both fundamental bacteriology and the emerging field of antibiotic tolerance.